Effectiveness of diabetes mellitus self management programme

A randomised controlled study of the effectiveness of diabetes mellitus (DM) self-management service in DM patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN78882965

Enrollment

120

Registered

2010-08-25

Start date

2007-04-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus Nutritional, Metabolic, Endocrine Diabetes mellitus

Interventions

Both intervention and control groups received their usual medical follow-ups in their GOPCs. The intervention group underwent the six sessions of weekly course of DM self-management service with empha

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients attending general outpatient clinics (GOPC) in Hospital Authority New Territory East Cluster 2. For patients with unstable DM control: HbA1C reaches 8.5 or greater 3. Capable of filling in study diary 4. Capable of giving informed written consent 5. Aged over 18 years, either sex

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

Measure	Time frame
1. HbA1c level, assessed during baseline, week 8 and week 28 2. DM self efficacy scale, assessed during baseline, week 8 and week 28 3. Dietary behaviours, assesed at baseline, week 8, week 16 and week 28 4. Exercise level, assesed at baseline, week 8, week 16 and week 28 5. Body mass index (BMI), assesed at baseline, week 8, week 16 and week 28 6. Waist-hip ratio, assesed at baseline, week 8, week 16 and week 28	—

Measure

Time frame

1. HbA1c level, assessed during baseline, week 8 and week 28 2. DM self efficacy scale, assessed during baseline, week 8 and week 28 3. Dietary behaviours, assesed at baseline, week 8, week 16 and week 28 4. Exercise level, assesed at baseline, week 8, week 16 and week 28 5. Body mass index (BMI), assesed at baseline, week 8, week 16 and week 28 6. Waist-hip ratio, assesed at baseline, week 8, week 16 and week 28

—

Secondary

Measure	Time frame
1. Improvement in urine albumin creatinine ratio between baselines and week 28 2. Improvement in blood pressure between baselines and week 28	—

Countries

Hong Kong

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 28, 2026